TITLE

Programs struggle to label all medications

PUB. DATE
July 2009
SOURCE
Same-Day Surgery;Jul2009, Vol. 33 Issue 7, special section p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on that the requirement 03.04.01 to label all medications is one of the National Patient Safety Goals (NPSGs) that health service providers struggle with the most.
ACCESSION #
42007368

 

Related Articles

  • PRACTICE PEARLS. Use discretion with drug expiration dates. Hitzeman, Nathan // Family Practice Management;Sep/Oct2012, Vol. 19 Issue 5, p32 

    The article discusses the findings by U.S. FDA and military which prove that most of the medications are good for use even after their expiry dates that are usually based on marketing perspectives.

  • Programs struggle to label all medications.  // Same-Day Surgery;Jul2009 Supplement, p2 

    The article reports that the requirement 03.04.01, which is the labeling of medications, is one of the National Patient Safety Goals (NPSGs) that health care providers find hard to comply.

  • FDA actions.  // Hospital Medicine Alert;Sep2013 Pharmacology Watch, p2 

    The article reports on the issuance of a Safety Communication by the U.S. Food and Drug Administration (FDA) on the oral antifungal ketoconazole that includes limiting the use of the drug.

  • New REMS for quinine. Elliott, William T. // Clinical Oncology Alert;Sep2010 Supplement, p2 

    This article reports on a new Risk Evaluation and Medication Strategy issued by the U.S. Food and Drug Administration for malaria drug Qualaquin, including a Medication Guide.

  • New REMS for quinine.  // Clinical Cardiology Alert;Sep2010 Clinical Briefs, p2 

    The article reports that a new Risk Evaluation and Medication Strategy (REMS) for Qualaquin has been released by the U.S. Food and Drug Administration (FDA).

  • FDA actions.  // Critical Care Alert;Sep2013 Pharmacology Watch, p2 

    The article focuses on the safety guidance issued by the U.S. Food and Drug Administration regarding ketoconazole, an oral antifungal, which mentions its drug interactions, risk of liver toxicity, and adrenal insufficiency.

  • FDA actions. Elliott, William T. // Clinical Cardiology Alert;Sep2013 Pharmacology Watch, p2 

    The article reports on the Safety Communication issued by the U.S. Food and Drug Administration (FDA) limiting the use of oral antifungal ketoconazole.

  • NATIONAL LABELLING. BRYCE, JULIANNE // Australian Nursing Journal;Apr2011, Vol. 18 Issue 9, p25 

    The article presents an overview of a document for Australian health care workers titled "The National Recommendations for User-Applied Labelling of Injectable Medicines, Fluids and Lines" which was endorsed by Australian health ministers and released by the Australian Commission on Safety and...

  • Should an Rx label require a use-by date or an expiration date? Rosenberg, Jack; Domovich, Aleksandr; Nathan, Joseph P.; Schilit, Sara // Drug Topics;2/11/2008, Vol. 152 Issue 3, p68 

    The article comments on issues concerning the requirement for an expiration date on prescription drug labels in the U.S. The Pharmaceutical Society of the State of New York (PSSNY) explains that it is impossible to assign an expiration date for dispensed drugs once they are removed from their...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics